Associated Pulmonary Arterial Hypertension

Known as: APAH 
Pulmonary hypertension that results from another disorder (e.g., connective tissue disorder).
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Although rare in its idiopathic form, pulmonary arterial hypertension (PAH) is not uncommon in association with various… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
Is this relevant?
Highly Cited
2013
Highly Cited
2013
BACKGROUND Systemic sclerosis–associated pulmonary artery hypertension (SScPAH) has a worse prognosis compared with idiopathic… (More)
  • table 1
  • table 2
Is this relevant?
Review
2010
Review
2010
Pulmonary arterial hypertension (PAH) is a devastating vascular complication of a number of connective tissue diseases, including… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND REVEAL (the Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension Disease Management) is the… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
RATIONALE Pulmonary arterial hypertension in association with connective tissue disease (CTD-PAH) has historically had a poor… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
RATIONALE The prevalence of HIV-associated pulmonary arterial hypertension (PAH) has not been evaluated since introduction of… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
OBJECTIVE To describe the response to first-line immunosuppressive therapy with or without pulmonary vasodilators in pulmonary… (More)
Is this relevant?
Review
2007
Review
2007
Pulmonary arterial hypertension associated with congenital heart disease, although common (15%-30%) in all-comers with congenital… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Dexfenfluramine associated pulmonary arterial hypertension occurring in a patient with hereditary haemorrhagic telangiectasia… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2003
Highly Cited
2003
OBJECTIVE To determine the prevalence of systemic sclerosis associated pulmonary arterial hypertension (SScPAH), evaluate outcome… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?